Biomedical journals probe peer review

Article Abstract:

Several editors and publishers of scientific and biomedical journals, researchers, and others gathered for the Fifth International Congress on Peer Review and Biomedical Publication to consider ways to improve the standard of published data and safeguard against dissemination of false and potentially dangerous information to researchers, physicians, and the public. Recent efforts to improve the quality of clinical research and publication include urging clinical trial registration.

Methods, Conferences, meetings and seminars, Medical publishing, Periodical editors

---

Researchers probe lupus causes, treatments

Article Abstract:

Researchers disclose some of the factors affecting the autoimmune disease systemic lupus erythematosus, including the disease onset, severity and remission. The current treatment strategies for systemic lupus include nonsteroidal antiinflammatory drugs, immunosuppresives, corticosteroids and antimalarial agents. Scientists are developing ways to design targeted therapies that are more effective that the current treatments.

Science & research, Research, Causes of, Drug therapy, Systemic lupus erythematosus, Lupus

---

Researchers probe nerve-blocking pain treatment for wounded soldiers

Article Abstract:

The military research findings that regional anesthesia may be better than traditional general anesthesia for treating soldiers with acute injuries.

Health aspects, Care and treatment, Injuries, Soldiers, Wounds and injuries, Regional anesthesia

Similar abstracts:

• Abstracts: Addressing Mental Health Needs of Balkan Refugees. Researchers report new clues to dementia. Institute probes music's therapeutic potential
• Abstracts: Safety improvements urged for MRI facilities. Researchers seek headway in bringing science to sports concussion treatment
• Abstracts: Strict NIH ethics rules provoke mixed response from scientists. Revolt in Bethesda
• Abstracts: In Europe, as in US, climate for embryo stem cell research is one of extremes. European researchers, drug companies join forces against rare diseases
• Abstracts: Lack of interferon response in animals to naked siRNAs. Is it a DC, is it an NK? No, it's an IKDC. Sensing the danger in RNA

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.